We provide you with 20 years of free, institutional-grade data for ALKS stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ALKS. Explore the full financial landscape of ALKS stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2024-02-21 | 1520262 | ALKS | 10-K | Url |
| 2023-10-25 | 1520262 | ALKS | 10-Q | Url |
| 2023-07-26 | 1520262 | ALKS | 10-Q | Url |
| 2023-04-26 | 1520262 | ALKS | 10-Q | Url |
| 2023-02-16 | 1520262 | ALKS | 10-K | Url |
| 2022-11-02 | 1520262 | ALKS | 10-Q | Url |
| 2022-07-27 | 1520262 | ALKS | 10-Q | Url |
| 2022-04-27 | 1520262 | ALKS | 10-Q | Url |
| 2022-02-16 | 1520262 | ALKS | 10-K | Url |
| 2021-10-27 | 1520262 | ALKS | 10-Q | Url |
| 2021-07-28 | 1520262 | ALKS | 10-Q | Url |
| 2021-04-28 | 1520262 | ALKS | 10-Q | Url |
| 2021-02-11 | 1520262 | ALKS | 10-K | Url |
| 2020-10-29 | 1520262 | ALKS | 10-Q | Url |
| 2020-07-29 | 1520262 | ALKS | 10-Q | Url |
| 2020-04-29 | 1520262 | ALKS | 10-Q | Url |
| 2020-02-13 | 1520262 | ALKS | 10-K | Url |
| 2019-10-23 | 1520262 | ALKS | 10-Q | Url |
| 2019-07-25 | 1520262 | ALKS | 10-Q | Url |
| 2019-04-25 | 1520262 | ALKS | 10-Q | Url |
| 2019-02-15 | 1520262 | ALKS | 10-K | Url |
| 2018-10-23 | 1520262 | ALKS | 10-Q | Url |
| 2018-07-26 | 1520262 | ALKS | 10-Q | Url |
| 2018-04-26 | 1520262 | ALKS | 10-Q | Url |
| 2018-02-16 | 1520262 | ALKS | 10-K | Url |
| 2017-10-26 | 1520262 | ALKS | 10-Q | Url |
| 2017-07-27 | 1520262 | ALKS | 10-Q | Url |
| 2017-04-27 | 1520262 | ALKS | 10-Q | Url |
| 2017-02-17 | 1520262 | ALKS | 10-K | Url |
| 2016-11-02 | 1520262 | ALKS | 10-Q | Url |
| 2016-07-28 | 1520262 | ALKS | 10-Q | Url |
| 2016-04-28 | 1520262 | ALKS | 10-Q | Url |
| 2016-02-25 | 1520262 | ALKS | 10-K | Url |
| 2015-10-29 | 1520262 | ALKS | 10-Q | Url |
| 2015-07-30 | 1520262 | ALKS | 10-Q | Url |
| 2015-04-30 | 1520262 | ALKS | 10-Q | Url |
| 2015-02-24 | 1520262 | ALKS | 10-K | Url |
| 2014-10-29 | 1520262 | ALKS | 10-Q | Url |
| 2014-07-31 | 1520262 | ALKS | 10-Q | Url |
| 2014-04-30 | 1520262 | ALKS | 10-Q | Url |
| 2013-10-31 | 1520262 | ALKS | 10-Q | Url |
| 2013-07-25 | 1520262 | ALKS | 10-Q | Url |
| 2013-05-23 | 1520262 | ALKS | 10-K | Url |
| 2013-01-31 | 1520262 | ALKS | 10-Q | Url |
| 2012-11-01 | 1520262 | ALKS | 10-Q | Url |
| 2012-07-26 | 1520262 | ALKS | 10-Q | Url |
| 2012-05-18 | 1520262 | ALKS | 10-K | Url |
| 2012-02-16 | 1520262 | ALKS | S-1 | Url |
| 2012-02-02 | 1520262 | ALKS | 10-Q | Url |
| 2011-11-03 | 1520262 | ALKS | 10-Q | Url |
Alkermes plc(NASDAQ:ALKS) 
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA (aripiprazole lauroxil), an e...
Website: http://www.alkermes.com
Founded: 1987
Full Time Employees: 2,235
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about ALKS stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.